Overview A Study of SHR4010 in Patients With Hemodialysis Status: Active, not recruiting Trial end date: 2020-05-28 Target enrollment: Participant gender: Summary The study is being conducted to evaluate the safety and pharmacokinetics of SHR0410 in patients with hemodialysis. Phase: Phase 1 Details Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.